Monarch Partners Asset Management’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$1.27M Buy
85,139
+42,579
+100% +$636K 0.38% 121
2022
Q3
$952K Buy
+42,560
New +$952K 0.29% 126